Advertisement
Icon WebMD Expert Blogs

Cancer Realities

From diagnosis and treatment to remission and survival

Important:

The opinions expressed in WebMD User-generated content areas like communities, review, ratings, or blogs are solely those of the User, who may or may not have... Expand

The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service or treatment.

Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.

Hide

Wednesday, November 21, 2012

Just Say “No” to Ridiculous Drug Prices

By Heather Millar

Health Care Costs

I’m not the kind of person who feels the need to balance my checkbook to the penny. I don’t pore over every credit card statement, looking for mistakes. While I’ve long found math concepts interesting, the detailed slog of actually doing math is not normally my passion. But the numbers on my medical bills fascinated me.

Mostly, I couldn’t believe the prices of the drugs I took to fight breast cancer: Herceptin, a monoclonal antibody, cost my insurance company about $10,000 a dose. Carboplatin, a traditional chemo drug, cost about the same. The anti-nausea drug Emend cost $800 for the three pills I took before and after each chemo infusion.

I’ve ranted about this to anyone who will listen ever since I became a cancer patient. I get that drug companies spend zillions developing drugs. Sure, they should benefit. That’s why U.S. law provides for patents that give drug makers a monopoly on their inventions for 17 years.

But what about Carboplatin? That drug’s patent expired years ago. Why does it still cost so much? My question: If these prices make no sense, then why do we, as patients, put up with them? Why doesn’t anyone speak up? Why aren’t there drug price protests?

Recently, at least one major cancer center—Memorial Sloan-Kettering in Manhattan where I got a second opinion in early days—has taken a stand against sky-high drug prices.

A month ago, doctors at MSKCC decided that they would not use a new drug, Zaltrap, for their patients with advanced colorectal cancer.  In an editorial they explained that the drug cost an average of $11,063 for one month of treatment. That is twice as much as an older drug. Does Zaltrap offer any extra benefit? The doctors said it did not, and so, they opted not to use it.

My favorite line: “In most industries something that offers no advantage over its competitors and yet sells for twice the price would never even get on the market.”

Part of the problem, the doctors wrote, is that the Food and Drug Administration approves drugs that are “safe and effective,” but doesn’t take into account relative costs once those drugs hit the market. As a result, the median price of chemo drugs has hovered around $10,000 since 2010. Two new drugs cost as much as $35,000 a month.

Amazingly, the drug’s developer, Sanofi, last week halved the price of Zaltrap. The drug company’s CEO cited “market resistance” to the “perceived relative price” of Zaltrap in the U.S.  He also claimed the MSKCC used a double dose in their comparison.

To me, these justifications sound pretty thin. If Sanofi can afford to give 50 percent discounts on a brand-new product, how can they deny that the higher charge was price-gouging?

Mostly, I think we cancer patients react to these ludicrous drug prices with a whimper. We’re scared. We’re sick. We’re tired. If we have insurance, it doesn’t affect us directly, or at least not immediately. If we don’t have insurance, God only knows how we cope.

The doctors have given us an example of what can be done if we just say, “No” to sky-high drug prices. I wonder how we patients can build upon that.   What do you think? How much do your drugs cost?

Photo: iStockphoto

Posted by: Heather Millar at 1:00 am

Comments

Leave a comment

Subscribe & Stay Informed

Cancer

Sign up for the Cancer newsletter and keep up with all the latest news, treatments, and research with WebMD.

Archives

WebMD Health News